SCHEMBL3086830

SCHEMBL3086830

O=C(Cl)C(Cl)(Cl)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
TSHR P16473 3/20 0.48
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
KCNN4 O15554 3/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
KIF11 P52732 3/20 0.38
PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2547243 0.82 CYP1A2 (0.65) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL7987418 0.82 CYP1A2 (0.58) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL8818467 0.80 CYP1A2 (0.56) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL1321231 0.80 CYP1A2 (0.70) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL6961047 0.80 CYP1A2 (0.56) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL659707 0.79 TSHR (0.52) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL8984631 0.78 CYP1A2 (0.54) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL4556174 0.78 MAPT (0.56) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL27651968 0.78 CYP1A2 (0.54) CYP1A2TSHRMAPTKMT2AKCNN4
SCHEMBL4946780 0.78 CYP1A2 (0.54) CYP1A2TSHRMAPTKMT2AKCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106133004-B Catalyst component for olefin polymerization 巴塞尔聚烯烃意大利有限公司 2019-05-07 CN disclosed
CN-108863774-A A kind of 2,4 dichloro benzene chloroacetic chloride synthetic method 石家庄市绿丰化工有限公司 2018-11-23 CN disclosed
CN-108658913-A A kind of method of synthetic pesticide Envidor key intermediate 石家庄市绿丰化工有限公司 2018-10-16 CN disclosed
CN-101951770-A Hcv protease inhibitors and uses thereof AVILA THERAPEUTICS INC 2011-01-19 CN disclosed
US-7799952-B2 Stereoselective method for the production of (R)-Dimepranol RATIOPHARM GMBH (DE) 2010-09-21 US disclosed
US-20090149677-A1 Stereoselective Method for the Production of (R)-Dimepranol RATIOPHARM GMBH (DE) 2009-06-11 US disclosed
US-7507827-B2 Stereoselective method for the production of Clopidogrel RATIOPHARM GMBH (DE) 2009-03-24 US disclosed
JP-2008184411-A METHOD FOR PRODUCING 2,2-DIFLUORO-PHENYLACETOACETATE CENTRAL GLASS CO LTD 2008-08-14 JP disclosed
JP-2008184410-A METHOD FOR PRODUCING 2,2-DIFLUORO-PHENYLACETOACETATE CENTRAL GLASS CO LTD 2008-08-14 JP disclosed
EP-1737868-B1 STEREOSELECTIVE METHOD FOR THE PRODUCTION OF CLOPIDOGREL RATIOPHARM GMBH (DE) 2008-02-27 EP disclosed
EP-0330360-A1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists SmithKline Beecham Farmaceutici S.p.A. (IT) 1989-08-30 EP disclosed
EP-0325406-A2 Diamine compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-07-26 EP disclosed
EP-0189774-B1 PROCESS FOR PRODUCTION OF N,N-DISUBSTITUTED CARBOXYLIC ACID AMIDES TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1989-04-12 EP disclosed
EP-0260555-A1 Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1988-03-23 EP disclosed
US-4691052-A Process for the preparation of pyrethroid acids S.C. JOHNSON & SON, INC. (US) 1987-09-01 US disclosed
EP-0189774-A1 Process for production of N,N-disubstituted carboxylic acid amides TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1986-08-06 EP disclosed
CN-86100282-A N, the manufacture method of N-two generations carboxylic acyloxy amine 1986-07-16 CN disclosed
EP-0116639-A4 ACYL GUANIDINES. RORER INTERNAT OVERSEAS INC (US) 1985-09-25 EP disclosed
EP-0116639-A1 ACYL GUANIDINES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1984-08-29 EP disclosed
WO-1984000875-A1 ACYL GUANIDINES RORER INT OVERSEAS (US) 1984-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149677-A1 Stereoselective Method for the Production of (R)-Dimepranol ADH5, ADH1A, ADH1C CYP1A2 26/4885TSHR 1515/4885MAPT 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.